Earlier this year, when the Indian government withdrew the bill on personal data protection, saying a more “comprehensive legal framework” needs to… Read […]
The Digital Personal Data Protection Bill 2022 – A snapshot
Month: December 2022
Drug & Medical Device Litigation India
ICLG – Drug & Medical Device Litigation – India Chapter covers regulatory frameworks, manufacturing, transactions, advertising, promotion and sales, data privacy, clinical trials […]
Patentability of stem cells related inventions in India
The science and technology of stem cells has evolved significantly since late 19th century. Patentability of stem cell technology has witnessed substantial growth in India […]
Cybersquatters riskier to handle, harder to punish
In the recent case of Adobe Inc v Namase Patel and Ors, the Delhi High Court imposed hefty penalties in a cybersquatting case brought […]
The Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules, 2022: Key Amendments
On October 28, 2022, the Ministry of Electronics and Information Technology (“MEITY”) notified [1] the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment […]
Recent Development On The Assessment Of Inventive Step In India
Novelty and inventive step are the foundational requirements for the grant of a patent application around the world. While novelty is a straight-forward […]
Nokia Vs Oppo: Nokia’s Application Rejected by the Delhi High Court
Nokia filed an application under Order 39 Rule 10 in the Delhi High Court to seek direction to Oppo to deposit, with the […]
Apple not falling far enough from the tree
In the recent case of Vinita Gupta v Amit Arora, the Delhi High Court considered the concept of semantic and conceptual similarity in […]
What is so inventive about the invention?
Inventive step has long been the main stumbling block for inventors seeking a patent for their invention. Manisha Singh and Aditya Goel explain […]
Patenting Genetic Scissors – Global Landscape and Indian Perspective
Manisha Singh, Partner, and Neha Ruhela, Senior Associate, of LexOrbis evaluate the use and patentability of the CRISPR-Cas system in India compared to […]